生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4139 生物科技

已收盘 07-17 16:00:00 EDT

906.10

+1.22

+0.13%

最高908.86	最低901.81	成交量10.94亿
今开904.88	昨收904.88	日振幅0.78%
总市值0.00	流通市值0.00	总股本0.00
成交额115.95亿	换手率--	流通股本0.00
市净率5.692685	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":906.0972,"timestamp":1752782399999,"preClose":904.87854,"halted":0,"volume":1093772024,"delay":0,"changeRate":0.001347,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":1.218689,"latestTime":"07-17 16:00:00 EDT","open":904.8777,"high":908.8552,"low":901.81024,"amount":11595260566.982527,"amplitude":0.007786,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752825600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.692685,"peRate":-67.466559,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2552458581","title":"Bioaffinity Technologies, Inc.7月17日成交额为57.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458581?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:21","pubTimestamp":1752801696,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Bioaffinity Technologies, Inc.成交额为57.12万美元，成交额较昨日减少25.00%，当日成交量为165.52万股。Bioaffinity Technologies, Inc.于2025年7月17日涨0.3%，报0.332美元，该股过去5个交易日涨7.06%，年初至今跌63.53%，过去60日跌33.22%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-17|57.12万|-25.00%|165.52万|#|2025-07-16|76.16万|-84.64%|237.82万|#|2025-07-15|495.77万|1596.42%|1678.34万|#|2025-07-14|29.22万|78.86%|100.88万|#|2025-07-11|16.34万|-33.87%|54.12万|bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092147a6b0d63a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092147a6b0d63a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"gpt_icon":0},{"id":"2552458585","title":"Bridgebio Pharma, Inc.7月17日成交额为5881.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458585?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:20","pubTimestamp":1752801622,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Bridgebio Pharma, Inc.成交额为5881.97万美元，成交额较昨日减少51.79%，当日成交量为125.49万股。Bridgebio Pharma, Inc.于2025年7月17日跌0.76%，报46.74美元，该股过去5个交易日涨1.02%，年初至今涨70.34%，过去60日涨39.48%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-17|5881.97万|-51.79%|125.49万|#|2025-07-16|1.22亿|7.00%|258.67万|#|2025-07-15|1.14亿|-38.45%|241.67万|#|2025-07-14|1.85亿|82.80%|386.12万|#|2025-07-11|1.01亿|-9.74%|218.80万|BridgeBio Pharma是一家生物技术公司，专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092024a4522474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092024a4522474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","BBIO","BK4588"],"gpt_icon":0},{"id":"2552320458","title":"Alterity Therapeutics Limited7月17日成交额为17.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552320458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552320458?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:18","pubTimestamp":1752801506,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Alterity Therapeutics Limited成交额为17.08万美元，成交额较昨日减少10.06%，当日成交量为3.66万股。Alterity Therapeutics Limited于2025年7月17日跌0.65%，报4.61美元，该股过去5个交易日涨18.51%，年初至今涨39.27%，过去60日涨33.62%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-17|17.08万|-10.06%|3.66万|#|2025-07-16|18.99万|5.21%|4.10万|#|2025-07-15|18.05万|-43.38%|3.96万|#|2025-07-14|31.88万|-90.19%|7.00万|#|2025-07-11|325.07万|2173.34%|65.94万|Alterity Therapeutics Ltd 活跃在医疗保健领域。该集团经营单一的部门，即帕金森病和其他神经退行性疾病的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091832a452235b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091832a452235b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","ATHE","PRNAF"],"gpt_icon":0},{"id":"2552458325","title":"Argenx Se7月17日成交额为2.57亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458325?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:17","pubTimestamp":1752801459,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Argenx Se成交额为2.57亿美元，成交额较昨日减少3.55%，当日成交量为45.11万股。Argenx Se于2025年7月17日跌0.9%，报572.71美元，该股过去5个交易日涨1.67%，年初至今跌6.88%，过去60日跌3.86%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091742a6b0d3ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091742a6b0d3ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4505","BK4588","ARGX","BK4139","LU0889565916.HKD","LU0109394709.USD","BK4585"],"gpt_icon":0},{"id":"2552458343","title":"知临集团7月17日成交额为822.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458343?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:17","pubTimestamp":1752801437,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，知临集团成交额为822.97万美元，成交额较昨日减少98.65%，当日成交量为427.35万股。知临集团于2025年7月17日涨1.55%，报1.97美元，该股过去5个交易日涨111.83%，年初至今跌29.64%，过去60日涨129.07%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-17|822.97万|-98.65%|427.35万|#|2025-07-16|6.12亿|2901103.62%|1.96亿|#|2025-07-15|2.11万|-46.94%|2.19万|#|2025-07-14|3.97万|30.58%|4.15万|#|2025-07-11|3.04万|-29.20%|3.26万|知临集团有限公司是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091727a6b0d3c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091727a6b0d3c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APM"],"gpt_icon":1},{"id":"2552445831","title":"阿诺医药7月17日成交额为5899.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552445831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552445831?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:16","pubTimestamp":1752801408,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，阿诺医药成交额为5899.00美元，成交额较昨日增加69.12%，当日成交量为3911.00股。阿诺医药于2025年7月17日跌0.66%，报1.5美元，该股过去5个交易日跌0.66%，年初至今跌44.24%，过去60日跌12.28%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-17|5899.00|69.12%|3911.00|#|2025-07-16|3488.00|233.14%|2271.00|#|2025-07-15|1047.00|-97.11%|669.00|#|2025-07-14|3.63万|3430.38%|2.38万|#|2025-07-11|1027.00|-94.44%|647.00|阿诺医药有限公司是一家临床阶段的生物技术公司，专注于为各种肿瘤类型的患者发现和开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091700a452228a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091700a452228a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANL","BK4139"],"gpt_icon":0},{"id":"2552307054","title":"信达玛仕度肽“闪电”商业化，中国减重药市场潜力被低估了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2552307054","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552307054?lang=zh_cn&edition=full","pubTime":"2025-07-18 08:27","pubTimestamp":1752798456,"startTime":"0","endTime":"0","summary":"信达生物减重新药玛仕度肽上市仅6天闪电开出首张处方，其以“院内快速覆盖+院外电商预售”破局，与众安保险推出“不瘦必赔”支付创新。凭借更优副作用控制、本土供应链及渠道效率，直击美国市场成本支付障碍痛点，展现中国减重药市场远超预期的独特潜力。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/7ed3cf61-ced6-4fbe-b6c0-caa349975d85.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/7ed3cf61-ced6-4fbe-b6c0-caa349975d85.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3751372","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3751372","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2552431165","title":"冠科美博盘中异动 临近收盘快速上涨7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552431165?lang=zh_cn&edition=full","pubTime":"2025-07-18 04:15","pubTimestamp":1752783354,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日04时15分，冠科美博股票出现异动，股价快速拉升7.32%。截至发稿，该股报6.45美元/股，成交量6037股，换手率0.55%，振幅6.16%。冠科美博股票所在的生物技术行业中，整体涨幅为0.29%。冠科美博公司简介：冠科美博有限公司是一家临床阶段的创新型生物制药公司，致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法，利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718041554a6b06cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718041554a6b06cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2552431578","title":"Surrozen, Inc.盘中异动 临近收盘大幅上涨6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552431578?lang=zh_cn&edition=full","pubTime":"2025-07-18 04:00","pubTimestamp":1752782420,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日04时00分，Surrozen, Inc.股票出现异动，股价急速拉升6.37%。Surrozen, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Surrozen, Inc.公司简介：Surrozen Inc 是一家临床阶段的生物技术公司，致力于发现和开发候选药物，以选择性地调节 Wnt 通路——一种多种器官和组织中组织修复的关键介质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071804002097aa2b1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071804002097aa2b1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SRZN","BK4139"],"gpt_icon":0},{"id":"2552431821","title":"Absci Corporation盘中异动 快速拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552431821?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:58","pubTimestamp":1752782318,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时58分，Absci Corporation股票出现波动，股价急速上涨5.47%。截至发稿，该股报2.89美元/股，成交量920.992万股，换手率7.22%，振幅5.84%。Absci Corporation股票所在的生物技术行业中，整体涨幅为0.27%。Absci Corporation公司简介：Absci Corp 是一家以人工智能为动力的合成生物学公司，致力于发掘蛋白质作为下一代疗法的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803583895468e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803583895468e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ABSI","BK4121"],"gpt_icon":0},{"id":"2552311594","title":"万基遗传盘中异动 股价大跌5.04%报4.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552311594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552311594?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:56","pubTimestamp":1752782214,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时56分，万基遗传股票出现异动，股价快速下跌5.04%。截至发稿，该股报4.81美元/股，成交量74.1547万股，换手率0.80%，振幅5.73%。万基遗传股票所在的生命科学行业中，整体涨幅为0.66%。其相关个股中，Prenetics Global Limited C/Wts 18/05/2027 、Mdxhealth Sa、Mainz Biomed N.V.涨幅较大，Applied Dna Sciences, Inc.、Caredx, Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为38.50%、26.79%、11.23%，振幅较大的相关个股有Caredx, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.，振幅分别为40.39%、19.92%、17.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718035654a6b06825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718035654a6b06825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MYGN","BK4139"],"gpt_icon":0},{"id":"2552431526","title":"Sunshine Biopharma Inc.盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552431526?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:48","pubTimestamp":1752781724,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时48分，Sunshine Biopharma Inc.股票出现异动，股价急速拉升5.25%。截至发稿，该股报1.60美元/股，成交量9.3475万股，换手率2.05%，振幅4.41%。Sunshine Biopharma Inc.股票所在的制药行业中，整体跌幅为2.05%。Sunshine Biopharma Inc.公司简介：Sunshine Biopharma Inc 是一家制药公司，提供并研究涵盖肿瘤学和抗病毒等多个治疗领域的救命药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718034844a6b066ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718034844a6b066ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SBFM"],"gpt_icon":0},{"id":"2552439148","title":"Bicycle Therapeutics Plc盘中异动 下午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439148?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:13","pubTimestamp":1752779622,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时13分，Bicycle Therapeutics Plc股票出现异动，股价急速上涨5.14%。Bicycle Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.29%。Bicycle Therapeutics Plc公司简介：Bicycle Therapeutics PLC 是一家临床阶段的生物制药公司，正在开发一种被称为 Bicycles 的新型药物。Bicycles 是合成的短肽，被限制形成两个环以稳定其结构几何形状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803134297aa214d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803134297aa214d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","BCYC"],"gpt_icon":0},{"id":"2552439463","title":"Syndax Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439463?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:12","pubTimestamp":1752779544,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时12分，Syndax Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.08%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法产品线。其候选产品包括 revumenib 和 axatilimab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718031224a6b05f0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718031224a6b05f0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNDX","BK4139"],"gpt_icon":0},{"id":"2552191439","title":"艾切托盘中异动 股价大涨5.14%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552191439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552191439?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:11","pubTimestamp":1752779463,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时11分，艾切托股票出现波动，股价快速上涨5.14%。截至发稿，该股报0.820美元/股，成交量27.8875万股，换手率0.34%，振幅7.17%。艾切托股票所在的生物技术行业中，整体涨幅为0.27%。艾切托公司简介：Adicet Bio Inc是一家临床阶段的生物技术公司，发现和开发用于癌症和其他疾病的异体γ δ T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507180311039546840f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507180311039546840f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2552439101","title":"Monte Rosa Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报5.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439101?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:07","pubTimestamp":1752779260,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时07分，Monte Rosa Therapeutics, Inc.股票出现波动，股价快速拉升5.08%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc是一家生物技术公司，专门开发分子胶降解剂，这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803074097aa2030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071803074097aa2030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLUE","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2552439192","title":"Alvotech C/Wts (To Pur Com)盘中异动 下午盘大幅跳水11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439192?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:00","pubTimestamp":1752778847,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时00分，Alvotech C/Wts 股票出现异动，股价快速下挫11.11%。Alvotech C/Wts 股票所在的制药行业中，整体跌幅为2.10%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Scilex Holding Company、Medicus Pharma Ltd C/Wts 15/11/2029涨幅较大，Incannex Healthcare Inc.、Shuttle Pharmaceuticals Holdings, Inc.、Gelteq Limited较为活跃，换手率分别为101.11%、16.21%、11.62%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Gelteq Limited、Scilex Holding Company，振幅分别为79.83%、23.53%、22.74%。Alvotech C/Wts 公司简介：Alvotech是一家综合性生物制药公司，致力于为全球患者开发和生产高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718030047a6b05c9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718030047a6b05c9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVOW","BK4139","ALVO"],"gpt_icon":0},{"id":"2552439678","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速拉升5.59%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439678?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:00","pubTimestamp":1752778821,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时00分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速上涨5.59%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.16%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718030022a451a7c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718030022a451a7c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2552439689","title":"Clene Inc.盘中异动 股价大涨5.31%报3.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439689?lang=zh_cn&edition=full","pubTime":"2025-07-18 02:50","pubTimestamp":1752778253,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日02时50分，Clene Inc.股票出现波动，股价快速拉升5.31%。截至发稿，该股报3.97美元/股，成交量3.7133万股，换手率0.41%，振幅4.83%。Clene Inc.股票所在的包装食品行业中，整体跌幅为0.37%。Clene Inc.公司简介：Clene Inc是一家临床阶段的制药公司，致力于发现、开发和商业化新型清洁表面纳米技术  疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802505495467f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802505495467f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLNN"],"gpt_icon":0},{"id":"2552443973","title":"Pharming Group Nv盘中异动 下午盘快速拉升6.53%报10.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552443973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552443973?lang=zh_cn&edition=full","pubTime":"2025-07-18 02:49","pubTimestamp":1752778153,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日02时49分，Pharming Group Nv股票出现异动，股价快速上涨6.53%。截至发稿，该股报10.92美元/股，成交量1.1731万股，换手率0.02%，振幅5.28%。Pharming Group Nv股票所在的生物技术行业中，整体涨幅为0.20%。Pharming Group Nv公司简介：Pharming Group 是一家生物制药公司，致力于改变罕见、衰弱和危及生命的疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802491395467f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802491395467f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHAR"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.0357},{"period":"3month","weight":0.1858},{"period":"6month","weight":0.0446},{"period":"1year","weight":0.1051},{"period":"ytd","weight":0.0651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}